{
  "created_at": "Sat Jan 29 23:56:23 +0000 2022",
  "id_str": "1487568512809947141",
  "full_text": "The FDA has hailed psilocybin—the psychoactive compound in “magic mushrooms”—as a “breakthrough therapy” in treating severe depression https://t.co/d7tA2ROa69",
  "display_text_range": [
    0,
    158
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/d7tA2ROa69",
        "expanded_url": "https://econ.st/34aOmNx",
        "display_url": "econ.st/34aOmNx",
        "indices": [
          135,
          158
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 41,
  "favorite_count": 122,
  "possibly_sensitive": false,
  "original_created_at": "Sat Jan 29 23:29:05 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "FDAは、シロシビン（「マジックマッシュルーム」に含まれる精神活性化合物）を、重度のうつ病の治療における「画期的な治療法」として歓迎しているhttps://t.co/d7tA2ROa69。"
    },
    {
      "locale": "zh",
      "full_text": "美国食品和药物管理局称赞迷幻药--\"神奇蘑菇 \"中的精神活性化合物--是治疗严重抑郁症的 \"突破性疗法 \"https://t.co/d7tA2ROa69。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "美國食品和藥物管理局稱讚迷幻藥--\"神奇蘑菇 \"中的精神活性化合物--是治療嚴重抑鬱症的 \"突破性療法 \"https://t.co/d7tA2ROa69。"
    }
  ]
}